ClinicalTrials.gg
Not yet recruitingNCT06835101Updated Feb 19, 2025

Perioperative Music in Obese Patients Under Spinal Anesthesia

A Phase 2 interventional study of Music intervention and Midazolam (sedative) in Obesity, Adolescent, sponsored by Asklepieion Voulas General Hospital. Not yet recruiting at 3 sites in Greece. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-02-19.

Sponsored by Asklepieion Voulas General Hospital · Phase 2, Interventional, and Supportive care

From the registry’s dates

  • Primary completion was expected by Dec 2025, 11 months ago, but the record still lists the study as not yet recruiting.
Phase
Phase 2
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to learn whether music or midazolam has a greater anxiolytic effect on obese patients undergoing spinal anesthesia. It will also determine the safety of music compared to midazolam in this population (differences in blood pressure, heart rate, oxygen saturation). The main question to answer: Music or midazolam is more effective in reducing anxiety in obese patients under spinal anesthesia?

02

Conditions studied

  • Obesity, Adolescent

Keywords

  • obese
  • music
  • anxiety
03

In context

Pediatric Obesity

1,129 studies on the registry are indexed under Pediatric Obesity; 187 are open to participants now.

This study's planned enrollment of 40 is below the median of 100 across 870 interventional studies indexed under Pediatric Obesity.

Browse Pediatric Obesity studies →

Lead sponsor

Asklepieion Voulas General Hospital is the lead sponsor of 13 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • patients who are > 18 years old
  • patients with -ΒΜΙ>30 kg/m2
  • patients who will give in receiving spinal anaesthesia
  • patients who will give informed consent in participating in the study

Exclusion criteria

Exclusion Criteria:

  • absolute of spinal anaesthesia,
  • severe psychiatric, cognitive or sensory impairment
  • mother language other than greek,
  • known to midazolam,
  • renal impairment
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

05

Study design

Phase
Phase 2
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Active comparator
    Music group

    The "music" group will receive music beginning 20 minutes before spinal anesthesia until the end of surgery.

    Other: Music intervention

  • Active comparator
    Midazolam group

    The "midazolam" group will receive increments of midazolam beginning 20 minutes before spinal anesthesia.

    Drug: Midazolam (sedative)

Interventions

  • OtherMusic intervention

    The "music" group will receive music beginning 20 minutes before spinal anesthesia until the end of surgery.

  • The "midazolam" group will receive increments of midazolam beginning 20 minutes before spinal anesthesia.

06

What researchers measure

Primary outcomes

  1. Spielberger State-Trait Anxiety Inventory (STAI): State -anxiety immediately after spinal anesthesia.

    State -anxiety, how the person feels at the moment, is measured by means of Spielberger State-Trait Anxiety Inventory (STAI). STAI tool scores range from 20 to 80, with higher scores indicating higher anxiety. Although it is difficult to represent severity of anxiety with a numerical cut-off, a score of 50 or higher has been shown to be associated with a higher level of anxiety.

    Time frame: State -anxiety is measured immediately after spinal anesthesia.

Secondary outcomes

  1. Spielberger State-Trait Anxiety Inventory (STAI): State -anxiety immediately after surgery

    State -anxiety, how the person feels at the moment, is measured by means of Spielberger State-Trait Anxiety Inventory (STAI). STAI tool scores range from 20 to 80, with higher scores indicating higher anxiety. Although it is difficult to represent severity of anxiety with a numerical cut-off, a score of 50 or higher has been shown to be associated with a higher level of anxiety.

    Time frame: Immediately after surgery

  2. Time performing spinal anesthesia

    Time needed for spinal anesthesia performance, measured in minutes

    Time frame: From the start of positioning maneuvers for spinal anesthesia to the spinal needle removal

  3. Patient satisfaction 24 hours after surgery

    The patient will be asked 24 hours after surgery whether he/she is satisfied (yes/no) with anesthesia.

    Time frame: 24 hours after surgery

  4. Communication difficulties between the patient and the anesthesiologist.

    The patient will be asked if there was any problem communicating with the anesthesiologist.

    Time frame: Immediately after surgery

  5. Communication difficulties between the anesthesiologist and the patient.

    The anesthesiologist will record any difficulty in communication with the patient during spinal anesthesia.

    Time frame: Immediately after surgery

  6. Adverse outcomes

    Any adverse outcome during the operation will be recorded.

    Time frame: During the operation

07

Study locations

3 sites
  • Asklepieion Hospital of Voula
    Athens, Voula 16673, Greece
  • General Hospital of Kavala
    Kavala, 65500, Greece
  • General Hopsital of Rethymno
    Rethymno, 74100, Greece
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Feb 2025; primary completion for Dec 2025, 10 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 15, 2025
First posted
Feb 19, 2025
StartEst.
Feb 2025
Primary completionEst.
Dec 2025
CompletionEst.
Dec 2025
Last update
Feb 19, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 19, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06835101
Lead sponsor
Asklepieion Voulas General Hospital
Responsible party
Maria Diakomi (Consultant Anaesthesiologist, General Hospital of Kavala) — Principal investigator
First posted
Feb 19, 2025
Start date
Feb 2025 (estimated)
Primary completion
Dec 2025 (estimated)
Completion
Dec 2025 (estimated)
Last update
Feb 19, 2025

Study contacts

Alexandros Makris, PhD
Contact
makrisalexandros@hotmail.com
00306947076446
Maria Diakomi, PhD
Contact
m.diakomi@yahoo.com
00306948886101

Oversight

Data monitoring committee
No
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Midazolam

Start the discussion